Category - Cardiology
Study to Explore Cangrelor vs. Glycoprotein IIa/IIb Inhibitors to Bridge or Not to Bridge In the Periprocedural Settings
Empagliflozin for HF-pEF and Its Effects on Patients Irrespective of Glycemic Status
ACC’s Physician Fee Schedule Proposed Rule Calculator Now Updated for 2023
Early Rhythm Control Therapy Effects With Atrial Fibrillation
VISUALIZED: Early Rhythm Control Therapy Effects With Atrial Fibrillation
Links Found Between COVID-19 Post-Recovery and Incident Heart Failure
Improved Outcomes In Age-Irrespective Heart Failure and Preserved Ejection Fraction Patients From Empagliflozin Treatment
ARNI vs. ACEi In Reducing Heart Failure Events Post-Myocardial Infection: The PARADISE-MI Trial
